Clinical Trials List
2021-12-30 - 2027-04-30
Phase III
Recruiting6
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 阮雍順 Division of Urology
- 李政學 Division of Urology
- Tsung-Yi Huang Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- YEN-HENG LIN Division of Urology
- FU-JEN HSUEH Division of Urology
- 劉詩彬 Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yi-Hsiu Huang Division of Urology
- 陳威任 Division of Urology
- Jiun-I Lai Division of Urology
- William Huang Division of Urology
- Tzu-Hao Huang Division of Urology
- 沈書慧 Division of Urology
- Chih-Chieh Lin Division of Urology
- I-Shen Huang Division of Urology
- Yen-Hwa Chang Division of Urology
- Tzu-chun Wei Division of Urology
- Chien-Hsin Ting Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chuan-Shu Chen Division of Urology
- Shian-Shiang Wang Division of Urology
- 蔡世傳 Division of Urology
- 盧嘉文 Division of Urology
- 裘坤元 Division of Urology
- 林雁婷 Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Che-Yuan Hu Division of Urology
- Yuh-Shyan Tsai Division of Urology
- 楊舜如 Division of Urology
- Jiann-Hui Ou Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yung-Chia Kao Division of Urology
- 黃文冠 Division of Urology
- Feng-Yuan Liu Division of Urology
- Kai-Jie Yu Division of Urology
- Yung-Chang Lin Division of Urology
- 張鈞弼 Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
550 participants
